Brief: ReShape Lifesciences Reports Q2 2022 Results
Aug 15 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES™ REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* RESHAPE LIFESCIENCES-REVENUE TOTALED $2.9 MILLION FOR
THREE
MONTHS ENDED JUNE 30, REPRESENTING CONTRACTION OF 18.1%, OR
$0.6 MILLION FOR SAME PERIOD IN 2021
* CASH AND CASH EQUIVALENTS WERE $11.5 MILLION AS OF JUNE
30, 2022
Source text for Eikon: ID:nGNX3cZ63B
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity